logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Bipolar I Disorder Most Recent Episode Depression

    FiltersReset Filters
    5 results

    • latuda

      (lurasidone hydrochloride)
      Sumitomo Pharma America, Inc.
      Usage: LATUDA is indicated for the treatment of schizophrenia in patients aged 13-17, monotherapy for bipolar depression in those aged 10-17, and as adjunctive treatment with lithium or valproate for adult patients with bipolar depression.

    • lurasidone hydrochloride

      (Lurasidone Hydrochloride)
      Golden State Medical Supply, Inc.
      Usage: Lurasidone hydrochloride is indicated for the treatment of schizophrenia in adults and adolescents (13-17 years), and for monotherapy or adjunctive treatment in patients (10-17 years) with major depressive episodes associated with bipolar I disorder.

    • olanzapine

      (Olanzapine)
      Ascend Laboratories, LLC
      Usage: Oral olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), and as an adjunct to lithium or valproate for bipolar I disorder. It is also used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression.

    • olanzapine

      (Olanzapine)
      Upsher-Smith Laboratories, LLC
      Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (both manic/mixed episodes and maintenance), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also in combination). Cautions exist for pediatric use due to risks like weight gain and dyslipidemia.

    • vraylar

      (cariprazine)
      Allergan, Inc.
      Usage: VRAYLAR® is indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder, depressive episodes in bipolar I disorder, and as adjunctive therapy to antidepressants for major depressive disorder in adults.